Bin Li
Nanjing University of Chinese Medicine · 727 works · 16,716 citations · h-index 62
Top works
- Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
- Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.
- Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
- Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two‐hybrid system
- Targeting PI3K/Akt signal transduction for cancer therapy
- Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2
- Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition
- Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
- ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
- Advances in targeted therapy for esophageal cancer
- p202, an Interferon-inducible Modulator of Transcription, Inhibits Transcriptional Activation by the p53 Tumor Suppressor Protein, and a Segment from the p53-binding Protein 1 That Binds to p202 Overcomes This Inhibition
- Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
- Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
- Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial
- Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
- RETRACTED: Micro RNA ‐16 inhibits glioma cell growth and invasion through suppression of BCL 2 and the nuclear factor‐κB1/ MMP 9 signaling pathway
- Id‐1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway
- Abstract 108: In vitro and in vivo characterization of novel scorpion venom-based peptides for the treatment of colon cancer
- New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer
- Down‐regulation of miR‐214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist